Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | BMY | MRNA | AMGN | GILD |
| Company | Blueprint Medicines Corp | Bristol-Myers Squibb Company | Moderna Inc | Amgen Inc | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 91.74 | 49.89 | 71.85 | 337.03 | 84.39 |
| High | 93.66 | 50.04 | 71.97 | 338.70 | 84.65 |
| Low | 90.82 | 49.11 | 69.20 | 334.61 | 83.57 |
| Last | 92.26 | 49.42 | 69.26 | 336.45 | 84.36 |
| Change | +2.93 | -0.32 | -0.60 | +3.53 | +0.47 |
| % Change | +3.28% | -0.64% | -0.86% | +1.06% | +0.56% |
| Volume | 339,300 | 3,394,070 | 2,571,602 | 706,248 | 3,986,447 |
| 20-Day Average Volume | 543,356 | 8,330,097 | 5,395,712 | 1,712,303 | 6,444,454 |
| Previous Close | 89.33 | 49.74 | 69.86 | 332.92 | 83.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 90.35 | 49.11 | 75.16 | 329.66 | 80.10 |
| 20-Day Raw Stochastic | 61.16% | 65.21% | 23.89% | 92.10% | 94.86% |
| 20-Day Relative Strength | 46.68% | 55.95% | 33.32% | 58.74% | 72.82% |
| Weighted Alpha | +57.37 | -10.23 | -33.78 | +27.86 | +19.21 |
| Today's Opinion | 40% Sell | 72% Buy | 88% Sell | 96% Buy | 88% Buy |
| Previous Opinion | 56% Sell | 72% Buy | 88% Sell | 88% Buy | 88% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 56% Sell | 88% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.93% since 09/12/24 | +2.42% since 09/12/24 | -0.22% since 09/12/24 | +2.23% since 09/12/24 | +1.49% since 09/12/24 |
| Low | 84.38 on 09/13/24 | 48.20 on 09/13/24 | 65.55 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 |
| High | 93.66 on 09/19/24 | 50.41 on 09/17/24 | 75.37 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 |
| 1-Month | |||||
| %Chg | -4.27% since 08/19/24 | +0.21% since 08/19/24 | -22.71% since 08/19/24 | +2.88% since 08/19/24 | +13.36% since 08/19/24 |
| Low | 83.91 on 09/12/24 | 46.88 on 08/22/24 | 64.11 on 09/12/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 |
| High | 96.50 on 09/03/24 | 50.75 on 09/04/24 | 89.80 on 08/20/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | -14.15% since 06/18/24 | +21.06% since 06/18/24 | -47.83% since 06/18/24 | +10.27% since 06/18/24 | +33.65% since 06/18/24 |
| Low | 83.91 on 09/12/24 | 39.35 on 07/05/24 | 64.11 on 09/12/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 |
| High | 121.90 on 07/16/24 | 51.19 on 07/29/24 | 138.07 on 06/25/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | +4.14% since 03/19/24 | -4.62% since 03/19/24 | -33.85% since 03/19/24 | +24.17% since 03/19/24 | +14.97% since 03/19/24 |
| Low | 83.91 on 09/12/24 | 39.35 on 07/05/24 | 64.11 on 09/12/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 |
| High | 121.90 on 07/16/24 | 54.47 on 03/28/24 | 170.47 on 05/24/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,593,577 | 100,827,960 | 26,773,144 | 178,589,936 | 104,514,608 |
| Shares Outstanding, K | 62,617 | 2,027,100 | 383,240 | 536,435 | 1,245,853 |
| Annual Sales | 249,380,000 | 45,006,000,000 | 6,848,000,000 | 28,190,000,000 | 27,116,000,000 |
| Annual Net Income | -506,980,000 | 8,025,000,000 | -4,714,000,000 | 6,717,000,000 | 5,665,000,000 |
| Last Quarter Sales | 138,160,000 | 12,201,000,000 | 241,000,000 | 8,388,000,000 | 6,954,000,000 |
| Last Quarter Net Income | -49,990,000 | 1,680,000,000 | -1,279,000,000 | 746,000,000 | 1,614,000,000 |
| 60-Month Beta | 0.58 | 0.46 | 1.67 | 0.61 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 08/01/24 | 2.07 on 07/26/24 | -3.33 on 08/01/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 10/24/24 | 10/31/24 | 11/07/24 | 10/29/24 | 11/05/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | N/A | 08/16/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 0.00 | 17.89 | 17.67 |